Journal of Cosmetic and Laser Therapy

期刊全称Journal of Cosmetic and Laser Therapy
期刊缩写J COSMET LASER THER
涉及主题医学生物皮肤病科外科遗传学物理内科学病理光学量子力学激光器化学放射科免疫学解剖
期刊介绍

A unique journal that focuses on the application of cosmetic laser and light therapies on the skin. The Journal of Cosmetic & Laser Therapy provides a forum for stimulating and up-to-date studies demonstrating the wide range of therapeutic options for clinicians and surgeons involved in cosmetic and dermatological treatment. The journal is aimed at dermatologists, cosmetic surgeons, plastic and facial plastic surgeons, oculoplastic surgeons and all those interested in the rapidly expanding field of cosmetic and laser therapy. Features include: -Cosmetic surgery, including facial rejuvenation, hair removal and skin resurfacing -Use of lasers and other light sources for cosmetic and dermatological treatment -Applications of peeling agents, fillers, injectables, implants and other cosmetic modalities -Topical treatments -Practical tips and safety issues

期刊ISSNprint: 1476-4172 on-line: 1476-4180
历年影响因子
2024年 2023年 2022年 2021年 2020年 2019年 2018年 2017年
1.21.21.9822.2471.2660.951.1381.113
历年发表/被引量
年份202620252024202320222021202020192018201720162015
发表量103223162338462710810812458
被引量0214844134274373415171118771913967
h-Index46
自引率8.30%
涉及的研究领域DERMATOLOGY-SURGERY
2026年新锐分区
大类小类TOP期刊综述期刊
4区4区 皮肤病学N/A
4区外科
中科院2025年分区 ?
大类小类TOP期刊综述期刊
4区4区 皮肤病学
4区外科
WOS期刊分区

JCR学科分类

JCR分区学科名称收录数据库JCR分区分区排名
DERMATOLOGYSCIEQ367/96
SURGERYSCIEQ3190/312

JCI学科分类

JCI分区学科名称收录数据库JCI分区分区排名
DERMATOLOGYSCIEQ363/96
SURGERYSCIEQ3189/312
期刊主页http://www.tandfonline.com/toc/ijcl20/currenthttp://www.informahealthcare.com/jcl
投稿网址https://mc.manuscriptcentral.com/mclt
出版商Informa Healthcare
出版国家(地区)SWEDEN
出版语言English
出版周期Quarterly
每年出版文章数35
Gold OA文章占比6.67%
原创研究文献占比
(排除综述)
82.50%
SCI收录类型

Science Citation Index Expanded (SCIE)

Scopus (CiteScore)

PubMed链接http://www.ncbi.nlm.nih.gov/nlmcatalog?term=1476-4172%5BISSN%5D
平均审稿周期>12周,或约稿
平均录用比例容易
相关链接

您可以在上述网站查看该期刊的网友互动,及期刊影响力的其它指标。

注:上述信息均来源于网络,仅供查考,如有遗漏或信息错误,欢迎 向我反馈